Sonova (OTCMKTS:SONVY) Stock Rating Lowered by Barclays

Sonova (OTCMKTS:SONVY) was downgraded by equities researchers at Barclays from a “strong-buy” rating to a “hold” rating in a report released on Wednesday,Zacks.com reports.

A number of other research analysts have also weighed in on SONVY. The Goldman Sachs Group raised Sonova to a “strong sell” rating in a report on Tuesday, October 22nd. UBS Group upgraded shares of Sonova to a “hold” rating in a research report on Tuesday, August 13th.

Sonova Stock Up 1.6 %

SONVY opened at $69.75 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.45 and a debt-to-equity ratio of 0.63. The business has a 50 day moving average price of $72.44 and a two-hundred day moving average price of $66.75. Sonova has a 52 week low of $54.18 and a 52 week high of $77.56.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.